Pay in 4 interest-free payments of $7.09 Learn more
Ships within 48 hours · Estimated delivery Aug 22 - Aug 27
In comparison, tirzepatide, a dual GLP-1 and GIP agonist, has demonstrated superior results in both blood sugar control and weight loss in clinical trials, making it an attractive option for patients with obesity and type 2 diabetes." While Ozempic is not formally a weight loss drug, it make help you lose weight
Nature Communications, 15, 4548
When you look at the other aspects of GLP-1, GLP-1 becomes a very important hormone for the trophic benefits across a whole range of cardio vascular and neurological factors
However, GLP-1 RAs are often preferred for T2D subjects with obesity or cardiovascular disease, providing a potential for confounding by indication
10.1523/JNEUROSCI.2552-05.2005 J
